Trial document



drksid header

  DRKS00005159

Trial Description

start of 1:1-Block title

Title

Improvement of endogenous regeneration in female healthy volunteers through physical exercise “REBIRTH aktiv women”

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

Rebirth women

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

http://Keine

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

In a pilot study, we have shown that physical training on a regular basis has a significant positive influence on the cardio vascular system in men between 45 and 65 years. Aim of the study is to show that a six month physical training intervention leads to an improvement on aging markers and elevates the peak oxygen consumption in a cohort of 313 female volunteers with a mainly sedentary way of working. Further the influence of chonical inflammation (paradontal status) and the hormonal balance (post menopause) on the training intervention will be examined. A control group will start with the intervention after a waiting period of 6 months.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

In a pilot study, we have shown that physical training on a regular basis has a significant positive influence on the cardio vascular system in men between 45 and 65 years. Aim of the study is to show that a six month physical training intervention leads to an improvement on telomere length and elevates the peak oxygen consumption in a cohort of 313 female volunteers with a mainly sedentary way of working. Further the influence of chonical inflammation (paradontal status) and the hormonal balance (post menopause) on the training intervention will be examined. A control group will start with the intervention after a waiting period of 6 months.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?

[---]*

end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:

[---]*

end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00005159
  •   2013/09/25
  •   [---]*
  •   yes
  •   Approved
  •   6428, Ethikkommission der Medizinischen Hochschule Hannover
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   Healthy female volunteers
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Training intervention of 210 min per week over a period of 6 months. Training could be bicycling, ergometer training, swimming, walking, nordic-walking, jogging, running, rowing-ergometer, shoulder-arm-ergometer. Also daily activities will be relevant as physical activities.
  •   Waiting-control group of half of the study participants.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Interventional
  •   [---]*
  •   Randomized controlled trial
  •   Open (masking not used)
  •   [---]*
  •   Control group receives no treatment
  •   Prevention
  •   Parallel
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Differences in telomere length in mononuclear cells (cells will be drwan from venous blood) between baseline and after 6 months intervention. Peak oxygen consumption (VO2peak) at baseline and after 6 months.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Measurements from venous blood:
Oxidative stress (malondialdehyd, nitrate, nirtite), OxLDL, sodium, potassium, calcium, magnesium, phosphate, glucose, bilirubin, creatinine (eGFR), urea, urea acid, cholesterol, LDL cholesterol, HDL cholesterol, triglyceride, creatinkinase, Gamma-GT, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, ferritin, hs CRP, cystatine C, transferrinrezeptor, TSH, NTproBNP, LH, FSH, estradiol, progesterone, ex vivo stimulationtest TFNalpha.
Additionally, for later analyses of new or newly relevant parameters/biomarkers aliquots will be stored in the unified biobank hannover.
Measurements from arterialized capillary blood: lactate, glucose.
Measurement from Saliva: ROS.
Questionnaires:
WorkAbilityIndex, SF36, nutrition analyses
Other Measurements: systolic and diastolic blood pressure
Each measurement will be done at baseline and after 6 months.

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2013/11/20
  •   313
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Female
  •   45   Years
  •   65   Years
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

Females (45 - 65 years old) with a mainly sedentary way of work and no physical activity during leisure time.

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

- smoker -diabetes mellitus - operations during the last 8 weeks - artificial joint replacement less then 6 months before the start of the study - coronary/arterial disease - not medicamentous adequately treated hypertension - cancer - other diseases that interfere with physical activity.

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • MHH - HTTG Chirurgie
    • Mr.  Prof.  Axel  Haverich 
    • Carl-Neuberg-Str. 1
    • 30625  Hannover
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Medizinische Hochschule Hannover
    • Mr.  Prof. Dr.  Uwe  Tegtbur 
    • Carl-Neuberg-Str. 1
    • 30625  Hannover
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Medizinische Hochschule Hannover
    • Mr.  Julian  Eigendorf 
    • Carl-Neuberg-Str. 1
    • 30625  Hannover
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Rebirth Exzellenzcluster, MHH
    • Calrl-Neuberg-Str. 1
    • 30625  Hannover
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact materialSupport
  • start of 1:1-Block address otherSupport
    • Deutsche Herzstiftung
    • Vogtstraß 50
    • 60322  Frankfurt
    • Germany
    end of 1:1-Block address otherSupport
    start of 1:1-Block address contact otherSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact otherSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting complete, follow-up complete
  •   2015/03/26
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.